The short form of the zinc finger antiviral protein inhibits influenza a virus protein expression and is antagonized by the virus-encoded NS1

Journal of Virology

Volumn 91, Issue 2, 2017, Pages

  Tang, Qiannan ^a,b   Wang, Xinlu ^a   Gao, Guangxia ^a,b  

^a INSTITUTE OF BIOPHYSICS   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Influenza A virus; NS1; PB2; Virus host interactions; Zinc finger antiviral protein

Indexed keywords

BASIC PROTEIN; BASIC PROTEIN 2; NONSTRUCTURAL PROTEIN 1; POLYMERASE ACIDIC PROTEIN; RNA POLYMERASE; SIALIDASE; UNCLASSIFIED DRUG; ZINC FINGER ANTIVIRAL PROTEIN; ZINC FINGER PROTEIN; ANTIVIRUS AGENT; INS1 PROTEIN, INFLUENZA VIRUS; ISOPROTEIN; MESSENGER RNA; PB2 PROTEIN, INFLUENZAVIRUS A; RNA BINDING PROTEIN; RNA DIRECTED RNA POLYMERASE; VIRAL PROTEIN; VIRUS RNA;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENZYME INHIBITION; ENZYME MECHANISM; HUMAN; INFLUENZA A (H1N1); INFLUENZA A VIRUS (H1N1); LIMIT OF DETECTION; LIMIT OF QUANTITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; VIRUS REPLICATION; VIRUS STRAIN; ALTERNATIVE RNA SPLICING; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; INFLUENZA A VIRUS; METABOLISM; MUTATION; PROTEIN SYNTHESIS;

ALTERNATIVE SPLICING; ANTIVIRAL AGENTS; GENE EXPRESSION REGULATION, VIRAL; HUMANS; INFLUENZA A VIRUS; MUTATION; PROTEIN BIOSYNTHESIS; PROTEIN ISOFORMS; RNA REPLICASE; RNA, MESSENGER; RNA, VIRAL; RNA-BINDING PROTEINS; VIRAL NONSTRUCTURAL PROTEINS; VIRAL PROTEINS; VIRUS REPLICATION; ZINC FINGERS;

EID: 85008674803     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01909-16     Document Type: Article

References (42)

1. Ryman KD, Meier KC, Nangle EM, Ragsdale SL, Korneeva NL, Rhoads RE, MacDonald MR, Klimstra WB. 2005. Sindbis virus translation is inhibited by a PKR/RNase L-independent effector induced by alpha/beta interferon priming of dendritic cells. J Virol 79:1487-1499. https://doi.org/10.1128/JVI.79.3.1487-1499.2005.
2. Wang N, Dong Q, Li J, Jangra RK, Fan M, Brasier AR, Lemon SM, Pfeffer LM, Li K. 2010. Viral induction of the zinc finger antiviral protein is IRF3-dependent but NF-kappaB-independent. J Biol Chem 285: 6080-6090. https://doi.org/10.1074/jbc.M109.054486.
3. MacDonald MR, Machlin ES, Albin OR, Levy DE. 2007. The zinc finger antiviral protein acts synergistically with an interferon-induced factor for maximal activity against alphaviruses. J Virol 81:13509-13518. https://doi.org/10.1128/JVI.00402-07.
4. Bick MJ, Carroll JWN, Gao G, Goff SP, Rice CM, MacDonald MR. 2003. Expression of the zinc-finger antiviral protein inhibits alphavirus replication. J Virol 77:11555-11562. https://doi.org/10.1128/JVI.77.21.11555-11562.2003.
5. Muller S, Moller P, Bick MJ, Wurr S, Becker S, Gunther S, Kummerer BM. 2007 Inhibition of filovirus replication by the zinc finger antiviral protein. J Virol 81:2391-2400. https://doi.org/10.1128/JVI.01601-06.
6. Gao G, Guo X, Goff SP. 2002. Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein. Science 297:1703-1706. https://doi.org/10.1126/science.1074276.
7. Zhu Y, Chen G, Lv F, Wang X, Ji X, Xu Y, Sun J, Wu L, Zheng YT, Gao G. 2011 Zinc-finger antiviral protein inhibits HIV-1 infection by selectively targeting multiply spliced viral mRNAs for degradation. Proc Natl Acad Sci U S A 108:15834-15839. https://doi.org/10.1073/pnas.1101676108.
8. Mao R, Nie H, Cai D, Zhang J, Liu H, Yan R, Cuconati A, Block TM, Guo JT, Guo H. 2013. Inhibition of hepatitis B virus replication by the host zinc finger antiviral protein. PLoS Pathog 9:e1003494. https://doi.org/10.1371/journal.ppat.1003494.
9. Kerns JA, Emerman M, Malik HS. 2008. Positive selection and increased antiviral activity associated with the PARP-containing isoform of human zinc-finger antiviral protein. PLoS Genet 4:e21. https://doi.org/10.1371/journal.pgen.0040021.
10. Guo X, Carroll JW, MacDonald MR, Goff SP, Gao G. 2004. The zinc finger antiviral protein directly binds to specific viral mRNAs through the CCCH zinc finger motifs. J Virol 78:12781-12787. https://doi.org/10.1128/JVI.78.23.12781-12787.2004.
11. Guo X, Ma J, Sun J, Gao G. 2007. The zinc-finger antiviral protein recruits the RNA processing exosome to degrade the target mRNA. Proc Natl Acad Sci U S A 104:151-156. https://doi.org/10.1073/pnas.0607063104.
12. Chen G, Guo X, Lv F, Xu Y, Gao G. 2008. p72 DEAD box RNA helicase is required for optimal function of the zinc-finger antiviral protein. Proc Natl Acad Sci U S A 105:4352-4357. https://doi.org/10.1073/pnas.0712276105.
13. Chen S, Xu Y, Zhang K, Wang X, Sun J, Gao G, Liu Y. 2012. Structure of N-terminal domain of ZAP indicates how a zinc-finger protein recognizes complex RNA. Nat Struct Mol Biol 19:430-435. https://doi.org/10.1038/nsmb.2243.
14. Zhu Y, Wang X, Goff SP, Gao G. 2012. Translational repression precedes and is required for ZAP-mediated mRNA decay. EMBO J 31:4236-4246. https://doi.org/10.1038/emboj.2012.271.
15. Xuan Y, Gong D, Qi J, Han C, Deng H, Gao G. 2013. ZAP inhibits murine gammaherpesvirus 68 ORF64 expression and is antagonized by RTA. J Virol 87:2735-2743. https://doi.org/10.1128/JVI.03015-12.
16. Das K, Aramini JM, Ma LC, Krug RM, Arnold E. 2010. Structures of influenza A proteins and insights into antiviral drug targets. Nat Struct Mol Biol 17:530-538. https://doi.org/10.1038/nsmb.1779.
17. Krug RM, Aramini JM. 2009. Emerging antiviral targets for influenza A virus. Trends Pharmacol Sci 30:269-277. https://doi.org/10.1016/j.tips.2009.03.002.
18. Medina RA, Garcia-Sastre A. 2011. Influenza A viruses: new research developments. Nat Rev Microbiol 9:590-603. https://doi.org/10.1038/nrmicro2613.
19. Ehrhardt C, Seyer R, Hrincius ER, Eierhoff T, Wolff T, Ludwig S. 2010. Interplay between influenza A virus and the innate immune signaling. Microbes Infect 12:81-87. https://doi.org/10.1016/j.micinf.2009.09.007.
20. Hale BG, Randall RE, Ortin J, Jackson D. 2008. The multifunctional NS1 protein of influenza A viruses. J Gen Virol 89:2359-2376. https://doi.org/10.1099/vir.0.2008/004606-0.
21. Gack MU, Albrecht RA, Urano T, Inn KS, Huang IC, Carnero E, Farzan M, Inoue S, Jung JU, Garcia-Sastre A. 2009. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 5:439-449. https://doi.org/10.1016/j.chom.2009.04.006.
22. Min JY, Krug RM. 2006. The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: inhibiting the 2=-5= oligo(A) synthetase/RNase L pathway. Proc Natl Acad Sci U S A 103: 7100-7105. https://doi.org/10.1073/pnas.0602184103.
23. Bergmann M, Garcia-Sastre A, Carnero E, Pehamberger H, Wolff K, Palese P, Muster T. 2000. Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J Virol 74:6203-6206. https://doi.org/10.1128/JVI.74.13.6203-6206.2000.
24. Li S, Min JY, Krug RM, Sen GC. 2006. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology 349:13-21. https://doi.org/10.1016/j.virol.2006.01.005.
25. Hale BG, Jackson D, Chen YH, Lamb RA, Randall RE. 2006. Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci U S A 103:14194-14199. https://doi.org/10.1073/pnas.0606109103.
26. de la Luna S, Fortes P, Beloso A, Ortin J. 1995. Influenza virus NS1 protein enhances the rate of translation initiation of viral mRNAs. J Virol 69: 2427-2433.
27. Aragon T, de la Luna S, Novoa I, Carrasco L, Ortin J, Nieto A. 2000. Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus. Mol Cell Biol 20: 6259-6268. https://doi.org/10.1128/MCB.20.17.6259-6268.2000.
28. Burgui I, Aragon T, Ortin J, Nieto A. 2003. PABP1 and eIF4GI associate with influenza virus NS1 protein in viral mRNA translation initiation complexes. J Gen Virol 84:3263-3274. https://doi.org/10.1099/vir.0.19487-0.
29. Liu CH, Zhou L, Chen G, Krug RM. 2015. Battle between influenza A virus and a newly identified antiviral activity of the PARP-containing ZAPL protein. Proc Natl Acad Sci U S A 112:14048-14053. https://doi.org/10.1073/pnas.1509745112.
30. Wang X, Li MM, Zhao J, Li S, MacDonald MR, Rice CM, Gao X, Gao G. 2016 Sindbis virus can exploit a host antiviral protein to evade immune surveillance. J Virol 90:10247-10258. https://doi.org/10.1128/JVI.01487-16.
31. Goodier JL, Pereira GC, Cheung LE, Rose RJ, Kazazian HH, Jr. 2015. The broad-spectrum antiviral protein ZAP restricts human retrotransposition. PLoS Genet 11:e1005252. https://doi.org/10.1371/journal.pgen.1005252.
32. Krug RM. 2015. Functions of the influenza A virus NS1 protein in antiviral defense. Curr Opin Virol 12C:1-6. https://doi.org/10.1016/j.coviro.2015.01.0.
33. Yin C, Khan JA, Swapna GV, Ertekin A, Krug RM, Tong L, Montelione GT. 2007 Conserved surface features form the double-stranded RNA binding site of non-structural protein 1 (NS1) from influenza A and B viruses. J Biol Chem 282:20584-20592. https://doi.org/10.1074/jbc.M611619200.
34. Wang W, Riedel K, Lynch P, Chien CY, Montelione GT, Krug RM. 1999. RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids. RNA 5:195-205. https://doi.org/10.1017/S1355 838299981621.
35. Donelan NR, Basler CF, Garcia-Sastre A. 2003. A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice. J Virol 77: 13257-13266. https://doi.org/10.1128/JVI.77.24.13257-13266.2003.
36. Jiao P, Tian G, Li Y, Deng G, Jiang Y, Liu C, Liu W, Bu Z, Kawaoka Y, Chen H. 2008. A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice. J Virol 82: 1146-1154. https://doi.org/10.1128/JVI.01698-07.
37. Min JY, Li S, Sen GC, Krug RM. 2007. A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis. Virology 363:236-243. https://doi.org/10.1016/j.virol.2007.01.038.
38. Darapaneni V, Prabhaker VK, Kukol A. 2009. Large-scale analysis of influenza A virus sequences reveals potential drug target sites of nonstructural proteins. J Gen Virol 90:2124-2133. https://doi.org/10.1099/vir.0.011270-0.
39. Connor RI, Chen BK, Choe S, Landau NR. 1995. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206:935-944. https://doi.org/10.1006/viro.1995.1016.
40. Yu M, Liu X, Cao S, Zhao Z, Zhang K, Xie Q, Chen C, Gao S, Bi Y, Sun L, Ye X, Gao GF, Liu W. 2012. Identification and characterization of three novel nuclear export signals in the influenza A virus nucleoprotein. J Virol 86:4970-4980. https://doi.org/10.1128/JVI.06159-11.
41. Neumann G, Watanabe T, Ito H, Watanabe S, Goto H, Gao P, Hughes M, Perez DR, Donis R, Hoffmann E, Hobom G, Kawaoka Y. 1999. Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A 96:9345-9350. https://doi.org/10.1073/pnas.96.16.9345.
42. Huprikar J, Rabinowitz S. 1980. A simplified plaque assay for influenza viruses in Madin-Darby kidney (MDCK) cells. J Virol Methods 1:117-120. https://doi.org/10.1016/0166-0934(80)90020-8.